GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (LSE:BXP) » Definitions » Dividend Payout Ratio

Beximco Pharmaceuticals (LSE:BXP) Dividend Payout Ratio : 0.00 (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Beximco Pharmaceuticals Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Beximco Pharmaceuticals's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.00.

The historical rank and industry rank for Beximco Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

LSE:BXP' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09   Med: 0.19   Max: 0.34
Current: 0.26


During the past 13 years, the highest Dividend Payout Ratio of Beximco Pharmaceuticals was 0.34. The lowest was 0.09. And the median was 0.19.

LSE:BXP's Dividend Payout Ratio is ranked better than
69.61% of 431 companies
in the Drug Manufacturers industry
Industry Median: 0.37 vs LSE:BXP: 0.26

As of today (2024-12-15), the Dividend Yield % of Beximco Pharmaceuticals is 7.29%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Beximco Pharmaceuticals was 7.29%. The lowest was 0.42%. And the median was 1.52%.

Beximco Pharmaceuticals's Dividends per Share for the months ended in Sep. 2024 was £0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was 36.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 30.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Beximco Pharmaceuticals was 45.50% per year. The lowest was 6.30% per year. And the median was 36.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Beximco Pharmaceuticals Dividend Payout Ratio Historical Data

The historical data trend for Beximco Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Dividend Payout Ratio Chart

Beximco Pharmaceuticals Annual Data
Trend Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.13 0.30 0.34 0.27

Beximco Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.10 - - -

Competitive Comparison of Beximco Pharmaceuticals's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beximco Pharmaceuticals's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's Dividend Payout Ratio falls into.



Beximco Pharmaceuticals Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Beximco Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Jun. 2024 )/ EPS without NRI (A: Jun. 2024 )
=0.023/ 0.086
=0.27

Beximco Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ 0.025
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beximco Pharmaceuticals (LSE:BXP) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Beximco Pharmaceuticals Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beximco Pharmaceuticals Business Description

Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.